Fennec Pharmaceuticals (FENC) said Thursday it made the early repayment of $13 million of its roughly $32 million outstanding convertible debt facility with Petrichor Healthcare Capital Management.
The company used available cash to fund the repayment. The remaining $19 million will mature in September 2027.
Fennec said it expects its cash, cash equivalents and investment securities to be enough to fund planned operations into 2026.
The company's shares were down 0.7% in recent trading.
Price: 5.62, Change: -0.04, Percent Change: -0.71